Cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension. Influence of CPAP therapy;Kardiale funktion bei patienten mit obstruktivem schlafapnoesyndrom und behandelter arterieller hypertonie: Vorteile durch CPAP-therapie?

Medizinische Klinik

Volumn 101, Issue 1, 2006, Pages 1-8

  Duchna, Hans Werner ^a   Myslinski, Wojciech ^a,b   Dichmann, Manuel ^a,c   Rasche, Kurt ^c   Schultze Werninghaus, Gerhard ^a   Orth, Maritta ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c Akademisches Lehrkrankenhaus der Universität Düsseldorf   (Germany)

Author keywords

CPAP; Diastolic dysfunction; Hypertension; Left ventricular hypertrophy; OSAS; Pulmonary hypertension; Right ventricular hypertrophy

Indexed keywords

ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHY; LUNG ARTERY PRESSURE; POSITIVE END EXPIRATORY PRESSURE; PULMONARY HYPERTENSION; SLEEP APNEA SYNDROME; TIME SERIES ANALYSIS;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CONTINUOUS POSITIVE AIRWAY PRESSURE; DATA INTERPRETATION, STATISTICAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; HYPERTENSION; HYPERTENSION, PULMONARY; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PULMONARY ARTERY; SLEEP APNEA, OBSTRUCTIVE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 31344436934     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-006-1003-2     Document Type: Article

References (50)

1. Alchanatis M, Paradellis G, Pini H, et al. Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration 2000;67:367-71.
2. Alchanatis M, Tourkohoriti G, Kakouros S, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 2001;68:566-72.
3. American Sleep Disorders Association and Sleep Research Society, an American Sleep Disorders Association Report. Practice parameters for the indications for polysomnography and related procedures. Sleep 1997;20:406-22.
4. American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens 1992;5:207-9.
5. Arias MA, Garcia-Rio F, Alonso-Fernandez A, et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function. Circulation 2005;112:375-83.
6. Atwood CW, McCroy D, Garcia JG, et al. Pulmonary artery hypertension and sleep-disordered breathing. Chest 2004;126:72S-7S.
7. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
8. Bradley TD. Right and left ventricular functional impairment and sleep apnea. Clin Chest Med 1992;13:459-79.
9. Bradley TD, Floras JS. Sleep apnea and heart failure part I: Obstructive sleep apnea. Circulation 2003;107:1671-8.
10. Cacho A, Prakash R, Sarma R, et al. Usefulness of two-dimensional echocardiography in diagnosing right ventricular hypertrophy. Chest 1983;84:154-7.
11. Chazan R, Najniger MJ, Przybylowski T, et al. Effect of continuous positive airway pressure (CPAP) on left ventricular diastolic function in patients with obstructive sleep apnea syndrome - OSAS. Pol Arch Med Wewn 1995;94:8-13.
12. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 Report. JAMA 2003;289:2560-71.
13. Cloward TW, Walker JM, Farney RJ, et al. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal contiuous positive airway pressure. Chest 2003;124:594-601.
14. Devereux R. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization and comparisons to other methods. Hypertension 1987;9:9-26.
15. Doherty LS, Kiely JL, Swan V, et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005;127:2076-84.
16. Duchna H-W, Grote L, Andreas S, et al. und Arbeitsgruppe Kreislauf und Schlaf der DGSM. State of the art article: Sleep-disordered breathing and cardio- and cerebrovascular diseases: update 2003 of clinical significance and future perspectives. Somnologie 2003;7:101-21.
17. Duchna H-W, Guilleminault C, Stoohs RA, et al. Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2000;161:187-91.
18. Duchna H-W, Orth M, Schultze-Werninghaus G, et al. Long-term effects of nasal CPAP on vasodilatory endothelial function in obstructive sleep apnea syndrome. Sleep Breath 2005;9:97-103.
19. Dursunoglu D, Dursunoglu N, Evrengul H, et al. Impact of obstructive sleep apnoea on left ventricular mass and global function. Eur Respir J 2005;26:283-8.
20. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 1995;98:118-28.
21. Fletcher EC. Cardiovascular effects of continuous positive airway pressure in obstructive sleep apnea. Sleep 2000;23:Suppl 4:S154-7.
22. Fröhlich ED, Chobanian AV, Devereux RB, et al. The heart in hypertension. N Engl J Med 1992;327:998-1008.
23. Guidry UC, Mendes LA, Evans JC, et al. Echocardiographic features of the right heart in sleep-disordered breathing. Am J Respir Crit Care Med 2001;164:933-8.
24. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990;8:941-6.
25. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-5.
26. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233-41.
27. Kitabatake A, Inoyue M, Asao M, et al. Noninvasive evaluation of pulmonary hypertension by pulsed Doppler technique. Circulation 1983;68:302-9.
28. Kribbs N, Pack A, Klein L, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:887-95.
29. Laaban JP, Pascal-Saboun S, Bloch E, et al. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 2002;122:1133-8.
30. Lentner C. Geigy scientific tables. Heart and circulation, vol 5. Basel: Geigy, 1990.
31. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
32. Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004;169:361-6.
33. Marti S, Sampol G, Munoz X, et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002;20:1511-8.
34. Möller DS, Lind P, Strunge B, et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003;16:274-80.
35. Narkiewicz K, Kato M, Phillips BG, et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999;100:2332-5.
36. Nieto FJ, Herrington DM, Redline S, et al. Sleep apnea and markers of vascular endothelial dysfunction in a large community sample of older adults. Am J Respir Crit Care Med 2004;169:354-60.
37. Nieto FJ, Young T, Lind B, et al. Sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000;283:1829-36.
38. Niroumand M, Kuperstein R, Sasson Z, et al. Impact of obstructive sleep apnea on left ventricular mass and diastolic function. Am J Respir Crit Care Med 2001;163:1632-6.
39. Noda A, Okada T, Yasuma F, et al. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995;107:1538-44.
40. Peperell JCT, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized parallel trial. Lancet 2002;359:204-10.
41. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
42. Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future - report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation 2004;109:951-7.
43. Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002;165:152-8.
44. Sanner B, Konermann M, Sturm A. Strukturelle kardiale Veränderungen bei Patienten mit obstruktiver Schlafapnoe. Z Kardiol 1995;84:360-4.
45. Schannwell CM, Steiner S, Hennersdorf MG, et al. Kardiovaskuläre Endorganschäden des Hochdrucks. Internist (Berl) 2005;46:496-508.
46. Schiffrin EL. Vascular remodeling and endothelial function in hypertensive patients: effects of antihypertensive therapy. Scand Cardiovasc J 1998;47:15-21.
47. Steiner S, Schwartzkopff B, Strauer BE, et al. Schlafapnoe: Risiko für die Herzinsuffizienz - Pathophysiologie, Diagnostik und Therapie. Dtsch Med Wochenschr 2005;130:468-72.
48. Steiner S, Strauer BE. Funktionelle Dynamik des rechten Ventrikels und des Lungenkreislaules bei obstruktiver Schlafapnoe - therapeutische Konsequenzen. Internist (Berl) 2004;45:1101-7.
49. Teichholz LE, Kreulen T, Herman MV, et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976;37:7-11.
50. Working Group Report. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J 1998;19:990-1003.